109 related articles for article (PubMed ID: 19100646)
1. The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets?
Stacher E; Gruber-Mösenbacher U; Halbwedl I; Dei Tos AP; Cavazza A; Papotti M; Carvalho L; Huber M; Ermert L; Popper HH
Lung Cancer; 2009 Jul; 65(1):49-55. PubMed ID: 19100646
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas.
Itakura E; Yamamoto H; Oda Y; Tsuneyoshi M
J Surg Oncol; 2008 Jan; 97(1):74-81. PubMed ID: 18041747
[TBL] [Abstract][Full Text] [Related]
3. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Lohela M; Bry M; Tammela T; Alitalo K
Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
[TBL] [Abstract][Full Text] [Related]
4. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor.
Park MS; Ravi V; Araujo DM
Curr Opin Oncol; 2010 Jul; 22(4):351-5. PubMed ID: 20485168
[TBL] [Abstract][Full Text] [Related]
8. VEGF receptor signalling - in control of vascular function.
Olsson AK; Dimberg A; Kreuger J; Claesson-Welsh L
Nat Rev Mol Cell Biol; 2006 May; 7(5):359-71. PubMed ID: 16633338
[TBL] [Abstract][Full Text] [Related]
9. A series of vascular tumors and tumorlike lesions of the bladder.
Tavora F; Montgomery E; Epstein JI
Am J Surg Pathol; 2008 Aug; 32(8):1213-9. PubMed ID: 18580491
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic growth factor expression in benign and malignant vascular tumours.
Young RJ; Fernando M; Hughes D; Brown NJ; Woll PJ
Exp Mol Pathol; 2014 Aug; 97(1):148-53. PubMed ID: 24984271
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
13. The expression of vascular endothelial growth factor and its receptors in port-wine stains.
Vural E; Ramakrishnan J; Cetin N; Buckmiller L; Suen JY; Fan CY
Otolaryngol Head Neck Surg; 2008 Oct; 139(4):560-4. PubMed ID: 18922344
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor angiogenesis.
Gaur P; Bose D; Samuel S; Ellis LM
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
[TBL] [Abstract][Full Text] [Related]
15. Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas.
Mankey CC; McHugh JB; Thomas DG; Lucas DR
Histopathology; 2010 Feb; 56(3):364-71. PubMed ID: 20459536
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin receptor annexin II in vascular tumors including angiosarcoma.
Syed SP; Martin AM; Haupt HM; Arenas-Elliot CP; Brooks JJ
Hum Pathol; 2007 Mar; 38(3):508-13. PubMed ID: 17239928
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary epitheloid hemangioendothelioma: a peculiar rare tumor of vascular origin.
Datta CK; Mossallati S; Hess DR; Brager PM; Basha IS
W V Med J; 2000; 96(1):364-6. PubMed ID: 10734801
[TBL] [Abstract][Full Text] [Related]
18. Vascular proliferations of the breast.
Brodie C; Provenzano E
Histopathology; 2008 Jan; 52(1):30-44. PubMed ID: 18171415
[TBL] [Abstract][Full Text] [Related]
19. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy.
Deng J; Liang H; Sun D; Pan Y; Wang B; Guo Y
Surgery; 2009 Nov; 146(5):896-905. PubMed ID: 19744460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
